Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × danvatirsen × Head & Neck × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Gynecologic 1 Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1

Interventions

pembrolizumab 49 Cisplatin 46 Cetuximab 34 Radiotherapy 30 Radiotherapy, Intensity-Modulated 18 Docetaxel 18 Fluorouracil 17 Paclitaxel 16 Nivolumab 15 Carboplatin 15 Radiation 12 Everolimus 8 Biopsy 8 Surgical Procedures, Operative 7 Radiosurgery 7 Gemcitabine 7 Cyclophosphamide 7 Magnetic Resonance Spectroscopy 6 Capecitabine 6 epacadostat 5 avelumab 5 Surveys and Questionnaires 5 Dexamethasone 5 Celecoxib 5 spartalizumab 4 durvalumab 4 bempegaldesleukin 4 Radiotherapy, Conformal 4 Gefitinib 4 Erlotinib Hydrochloride 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05814666 2026-01-30

PEMDA-HN

Flamingo Therapeutics NV

Phase 2 Terminated

69 enrolled 21 charts

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon ⚡